About – Lumo Imaging

About Us

Our Mission

To help dermatologists detect skin cancers at an earlier stage by monitoring undesirable transformation of the skin lesions.

Our Vision

Lumo imaging is aiming provide the healthcare system with a highly sensitive, specific, and economical means of providing annual skin cancer screening to all at-risk individuals.

Using AI-Driven Total Body Photography (TBP) to Improve Public Health

Lumo is an R&D Stage company engaged in the development of full body skin cancer screening systems. Similarly to how women in risk of breast cancer receive annual mammograms, people at risk of skin cancer should receive annual Lumograms (well over 60M annual scans in US). In the runup to that vision, we have developed a number of offering that can make the dermatologist more effective and efficient.

Our Offerings

The LumoScanner System

The LumoScanner System (which includes the scanner hardware/software, an cloud-based scan archival system and a zero footprint total body photography (TBP) DICOM viewer software)

LumoTrack

LumoTrack, a clinical decision support system for highlighting suspicious lesions

Flacara

Flacara, the future of dermoscopy, an iPhone/iPad app that in addition to recording images of the lesions of interest, can also record their locations thereby allowing the doctors to follow-up on the lesions much more efficiently.

Executive Team

Davood Tashayyod

CEO

Former CEO fNIR Devices, Former Coulter Program Director, Responsible for commercializing 40 medical devices

Gregory Martin PhD

VP of Development

Former VP of R&D at Hologic

To be revealed

VP of Sales & Marketing

Track record of successful acquisition at companies including Hologic

Board

Davood Tashayyod

John Sheets, Ph.D

Former SVP R&D Boston Scientific,, Former Director, Office of Device Evaluation, FDA

Joyce Cowan

Healthcare Regulatory and Policy Specialist, Former Partner, Morgan Lewis

Advisory Board

Giuseppe Argenziano

Head of Dermatology, MD

Co-founder/Past president Int Dermoscopy Society; Authored 800+ articles with 23.000+ citations

Rebecca Hartman

MD, MPH

Assistant Professor, Dermatology, Harvard Medical School Director, Melanoma Epidemiology, Dermatology, Brigham And Women's Hospital

Sancy Leachman

MD, MPH

Professor & Chair of Dermatology at Oregon Health & Science University, Principal Investigator for the War on Melanoma, an all-fronts effort to eliminate melanoma

Amir Gandjbakhche, PhD

Senior Investigator, NIHCD

Senior Investigator, Section on Translational Biphotonic at NICHD Fellow of SPIE

Mehran Armand, PhD

Professor, JHU Orthopedic

Director of the Laboratory for Biomechanical and Image-Guided Surgical Systems (BIGSS)

Lumo Imaging is engineering and commercializing a first-ever, low-footprint, AI-driven TBP scanner to visualize skin anomalies across all dimensions of the human body.